injection site (left arm) is hot; injection site (left arm) is hot and with a circle red; injection site (left arm) very itchy; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site (left arm) very itchy), VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 28-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site (left arm) very itchy). On 05-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site (left arm) very itchy), VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reported Concomitant medications including Thyroids pills.    No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Feb-2021 and was forwarded to Moderna on 06-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site (left arm) very itchy), VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 28-Jan-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 04-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site (left arm) very itchy). On 05-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (injection site (left arm) very itchy), VACCINATION SITE WARMTH (injection site (left arm) is hot) and VACCINATION SITE ERYTHEMA (injection site (left arm) is hot and with a circle red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reported Concomitant medications including Thyroids pills.    No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.